logo.jpg
Sampo plc’s share buybacks 11 September 2024
September 12, 2024 01:30 ET | Sampo plc
SAMPO PLC                 STOCK EXCHANGE RELEASE                  12 September 2024 at 8:30 am Sampo plc’s share buybacks 11 September 2024 On 11 September 2024, Sampo plc (business code 0142213-3,...
logo.gif
BGHL (GBP): NAV(s)
September 12, 2024 01:30 ET | BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP)
                                      BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
image001.png
Transaction in Own Shares
September 12, 2024 01:30 ET | Endeavour Mining PLC
ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES London, 12 September 2024 – Endeavour Mining plc (LSE:EDV, TSX:EDV) (“the Company”) announces it has purchased the following number of its ordinary...
logo.gif
BGHL (EUR): NAV(s)
September 12, 2024 01:30 ET | BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)
                                      BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
logo.jpg
Avance Gas Holding Ltd: Presentation at the Pareto Securities' Energy Conference
September 12, 2024 01:01 ET | Avance Gas Holding Ltd
The CEO of Avance Gas Holding Ltd., Øystein Kalleklev, will be presenting at the Pareto Securities' Energy Conference today. The presentation used is attached hereto and is available on our web page...
Santhera Announces H
Santhera Announces Half-Year 2024 Financial Results and Provides Corporate Update
September 12, 2024 01:00 ET | Santhera Pharmaceuticals Holding AG
Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on September 12, 2024, at 14:30 CEST / 13:30 BST / 08:30 EDT. Details are at the end of this news release. Revenue from...
Start of Day Message
September 12, 2024 01:00 ET | GlobeNewswire, Inc.
LONDON, 12 Sep. 2024 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...
VivoryonLogo1.jpg
Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease
September 12, 2024 01:00 ET | Vivoryon Therapeutics N.V.
Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease Primary focus is developing...
Sanofi new_logo.jpg
Communiqué de presse : Accord de licence entre Sanofi, RadioMedix et Orano Med pour le développement d’une nouvelle génération de radiothérapies internes vectorisées contre les cancers rares
September 12, 2024 01:00 ET | Sanofi - Aventis Groupe
Accord de licence entre Sanofi, RadioMedix et Orano Med pour le développement d’une nouvelle génération de radiothérapies internes vectorisées contre les cancers rares Paris (France) et Houston...
Sanofi new_logo.jpg
Press Release: Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers
September 12, 2024 01:00 ET | Sanofi - Aventis Groupe
Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers Paris, France, and Houston, Texas, September 12, 2024....